Vertex to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8Business Wire • 12/18/23
Vertex Receives CHMP Positive Opinion for the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta ThalassemiaBusiness Wire • 12/15/23
Midday Movers: Vertex Surges on Gene-Editing Deal, Pfizer Falls on Guidance MissInvestopedia • 12/13/23
Vertex Breaks Out To Record High As It Takes On Opioids In Pain TreatmentInvestors Business Daily • 12/13/23